Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing pyridoxine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 10mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pyridoxine (as pyridoxine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 100mg/cc injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 100mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 100mg/mL injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 100mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pyridoxine hydrochloride 10mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 10mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridoxine (as pyridoxine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridoxine (as pyridoxine hydrochloride) 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 50 mg oral tablet |
Has precise active ingredient |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 10mg tablet (substance) |
Has precise active ingredient |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridoxine hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely pyridoxine hydrochloride 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 25 mg oral tablet |
Has precise active ingredient |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Pyridoxine hydrochloride 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely isoniazid 300 milligram and pyridoxine hydrochloride 25 milligram and sulfamethoxazole 800 milligram and trimethoprim 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Pyridoxine hydrochloride |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |